Why the study?
Does p38 MAPK inhibition with SB239063AN attenuate Angiotensin II-dependent hypertension, organ damage, and reactive oxygen species production in animal models?
Does p38 MAPK inhibition with SB239063AN attenuate Angiotensin II-dependent hypertension, organ damage, and reactive oxygen species production in animal models?
Answers are grounded in this paper and cite their sources.
Inhibition of p38 MAPK attenuates Angiotensin II-induced hypertension, cardiac hypertrophy, and oxidative stress in animal models, suggesting a potential therapeutic target for cardiovascular disease.
Angiotensin II (Ang II) activates p38 mitogen-activated protein kinase (p38 MAPK) and increases reactive oxygen species (ROS), but the nature of the relationship in vivo is not fully understood. We assess the effect of SB239063AN, a highly selective, orally active, p38 MAPK inhibitor, on Ang II-dependent hypertension, target-organ damage and ROS production. Sprague-Dawley rats and MAPKAP kinase-2 knockout mice were infused with Ang II. Ang II infusion increased the levels of phosphorylated p38 MAPK in the heart and aorta. Production of superoxide anion and expression of NAD(P)H oxidase subunit gp91 in the aorta were increased 4- and 5-fold, respectively. In addition, Ang II infusion led to endothelial dysfunction, progressive and sustained hypertension, and cardiac hypertrophy. Treatment with SB239063AN (800 ppm in the diet) significantly attenuated the levels of phosphorylated p38 MAPK in the heart and aorta, reduced superoxide anion generation by 57% (P < 0.01), markedly suppressed gp91 mRNA expression, prevented endothelial dysfunction, and blunted both the hypertension and cardiac hypertrophy. Ang II-dependent hypertension was also significantly attenuated in MAPKAP kinase-2 knockout mice. The results suggest that Ang II induced hypertension, organ damage, and ROS production are possibly mediated by p38 MAPK and inhibition of p38 MAPK may offer a therapeutic approach for cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: